Scientists hunt for clues to make breast cancer chemo more effective

NCT ID NCT03096418

Recruiting now Disease control Sponsor: University of Wisconsin, Madison Source: ClinicalTrials.gov ↗

Summary

This study aims to learn if a common chemotherapy drug (paclitaxel) works better against breast cancers that have a specific type of genetic instability. Researchers will give the drug to 50 women with breast cancer before their surgery and take multiple tumor samples to measure the drug's levels and effects. The goal is to find biological markers that can predict which patients will respond best to this treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST NEOPLASM FEMALE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University of Iowa Health Care/Holden Comprehensive Cancer Center
NOT_YET_RECRUITING

Iowa City, Iowa, 52242, United States

Contact
University of Wisconsin Carbone Cancer Center
RECRUITING

Madison, Wisconsin, 53792, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

BREAST NEOPLASM FEMALE